Wardill, H.Van Sebille, Y.Mander, K.Gibson, R.Logan, R.Bowen, J.Sonis, S.2015-11-022015-11-022015Cancer Treatment Reviews, 2015; 41(2):122-1280305-73721532-1967http://hdl.handle.net/2440/95997Abstract not availableen© 2014 Elsevier Ltd. All rights reserved.ChemotherapyNeurotoxicityNeuropathyGut toxicityToll-Like Receptor 4Glial activationToll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities an emerging hypothesis for neuropathy and gastrointestinal toxicityJournal article003001713110.1016/j.ctrv.2014.11.0050003495147000072-s2.0-849217684592-s2.0-84919346346163416Wardill, H. [0000-0002-6613-3661]Gibson, R. [0000-0002-4796-1621]Logan, R. [0000-0002-9331-1814]Bowen, J. [0000-0003-0876-0031]